Latest Expert Opinions

Signal
Opinion
Expert
DON'T BUY
DON'T BUY
November 15, 2018
He likes the restaurant but not the stock. It was a broken IPO. They are going to get rid of the bottom 10% of the stores. They missed expectations. We are getting into tax loss selling. He thinks they might privatize them down the road because the market will not appreciate them down the road.
Show full opinionHide full opinion
Freshii Inc (FRII-T)
November 15, 2018
He likes the restaurant but not the stock. It was a broken IPO. They are going to get rid of the bottom 10% of the stores. They missed expectations. We are getting into tax loss selling. He thinks they might privatize them down the road because the market will not appreciate them down the road.
BUY
BUY
November 15, 2018
A broadcast products company. They have a great cash position and made a recent acquisition. They grew the dividend over time. Every other company in the space got acquired in the past so they probably will. He likes it. It is for a steady income.
Show full opinionHide full opinion
A broadcast products company. They have a great cash position and made a recent acquisition. They grew the dividend over time. Every other company in the space got acquired in the past so they probably will. He likes it. It is for a steady income.
WEAK BUY
WEAK BUY
November 15, 2018
They ran into portfolio problems a couple of years ago and people were worried about write downs and yield cuts. Good dividend. They did a good job since. This is not a one quarter fix. He would be a cautious buyer. Problems are slowly getting resolved.
Show full opinionHide full opinion
Alaris Royalty (AD-T)
November 15, 2018
They ran into portfolio problems a couple of years ago and people were worried about write downs and yield cuts. Good dividend. They did a good job since. This is not a one quarter fix. He would be a cautious buyer. Problems are slowly getting resolved.
WAIT
WAIT
November 15, 2018
They came out of nowhere and won some big contracts. After a slump in orders some just came in. There is a much larger company in the space that has recently disappointed investors in terms of share price. It will weight down this one. Don’t step in now. Wait till the new year and take another look.
Show full opinionHide full opinion
They came out of nowhere and won some big contracts. After a slump in orders some just came in. There is a much larger company in the space that has recently disappointed investors in terms of share price. It will weight down this one. Don’t step in now. Wait till the new year and take another look.
BUY
BUY
November 15, 2018
They beat their numbers and came out with 2019-20 forecasts. Their consecutive growth rate should slow down. He thinks their share price is cheap. They are well financed. They have 5 solid years of history. At nine times earnings and 20% growth with a dividend that has been raised over time, he would be a contrarian and would step in now.
Show full opinionHide full opinion
goeasy (GSY-T)
November 15, 2018
They beat their numbers and came out with 2019-20 forecasts. Their consecutive growth rate should slow down. He thinks their share price is cheap. They are well financed. They have 5 solid years of history. At nine times earnings and 20% growth with a dividend that has been raised over time, he would be a contrarian and would step in now.
SELL
SELL
November 15, 2018
He has been disappointed in the company but in clinical trials and the FDA process, things don't go as well as you want. They ran into a cash crush so they extended the terms of their debt. It is way down and the time-frame is extended. You should move on. There is tax loss selling.
Show full opinionHide full opinion
He has been disappointed in the company but in clinical trials and the FDA process, things don't go as well as you want. They ran into a cash crush so they extended the terms of their debt. It is way down and the time-frame is extended. You should move on. There is tax loss selling.
BUY
BUY
November 15, 2018
He considers it a quality company and worth owning. He likes the balance sheet and the product. The management company has sold companies before. Put it away and don’t look at it on a daily basis.
Show full opinionHide full opinion
He considers it a quality company and worth owning. He likes the balance sheet and the product. The management company has sold companies before. Put it away and don’t look at it on a daily basis.